candesartan cilexetil has been researched along with Cardiomyopathy, Dilated in 5 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined effects of an angiotensin-II receptor blockers, candesartan cilexetil, in rats with dilated cardiomyopathy after autoimmune myocarditis." | 3.73 | Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy. ( Aizawa, Y; Inoue, M; Kashimura, T; Kodama, M; Ma, M; Saito, Y; Shirai, K; Suresh, PS; Tachikawa, H; Wahed, MI; Watanabe, K, 2005) |
| "The aims were (1) to investigate the effect of hypertention on left ventricular dilatation and haemodynamic alterations following acute myocardial infarction in spontaneously hypertensive rats (SHR) and normotensive rats (WKY); (2) to compare haemodynamic indices between the two groups; (3) to assess whether the angiotensin II type 1 receptor antagonist (AIIA), TCV-116, prevented left ventricular dilatation after myocardial infarction; and (4) to compare the effect of AIIA with that of the angiotensin converting enzyme (ACE) inhibitor, delapril." | 3.69 | An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. ( Nishikimi, T; Takeda, T; Takeuchi, K; Yamagishi, H, 1995) |
| "When candesartan cilexetil was administered to Bio TO2 hamsters, cardiac chymase-like activity increased significantly, whereas cardiac fibrosis decreased significantly." | 1.33 | Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters. ( Orito, K; Shimamura, S; Shimizu, M; Tanaka, R; Uchida, M; Yamane, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goineau, S | 1 |
| Nisse-Durgeat, S | 1 |
| Pape, D | 1 |
| Guillo, P | 1 |
| Ramée, MP | 1 |
| Bellissant, E | 1 |
| Shirai, K | 1 |
| Watanabe, K | 1 |
| Ma, M | 1 |
| Wahed, MI | 1 |
| Inoue, M | 1 |
| Saito, Y | 1 |
| Suresh, PS | 1 |
| Kashimura, T | 1 |
| Tachikawa, H | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
| Shimizu, M | 1 |
| Tanaka, R | 1 |
| Uchida, M | 1 |
| Orito, K | 1 |
| Shimamura, S | 1 |
| Yamane, Y | 1 |
| Nishikimi, T | 1 |
| Yamagishi, H | 1 |
| Takeuchi, K | 1 |
| Takeda, T | 1 |
| Matsumori, A | 1 |
| Sasayama, S | 1 |
1 review available for candesartan cilexetil and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; B | 1995 |
4 other studies available for candesartan cilexetil and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Systemic and regional hemodynamic and cardiac remodeling effects of candesartan in dilated cardiomyopathic hamsters with advanced congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 2002 |
Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoimmune Diseases; Benzimidazoles; Biph | 2005 |
Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; C | 2006 |
An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomyopath | 1995 |